Gossamer Bio Inc (NAS:GOSS)
$ 0.6833 -0.0107 (-1.54%) Market Cap: 154.57 Mil Enterprise Value: 121.66 Mil PE Ratio: 0 PB Ratio: 5.69 GF Score: 38/100

Q1 2019 Gossamer Bio Inc Earnings Call Transcript

May 14, 2019 / 12:30PM GMT
Release Date Price: $19.29 (-4.65%)
Operator

Good morning and welcome to the Gossamer Bio First Quarter 2019 Earnings Call. Today's call will feature updates from Gossamer Bio management team followed by a question-and-answer session.

I will now turn the call over to Gossamer's Chief Financial Officer, Bryan Giraudo. Bryan?

Bryan Giraudo
Gossamer Bio, Inc. - CFO

Thank you, operator, and thank you all for joining us this morning. With me on today's call is Gossamer's Co-founder and Chief Executive Officer Dr. Sheila Gujrathi.

Earlier this morning, Gossamer issued a press release announcing its financial results for the first quarter ended March 31, 2019, and provided a corporate update. Please noted that certain information discussed on the call today is covered under the safe harbor provision of the Private Securities Litigation Reform Act. We caution listeners that during this call Gossamer management will be making forward-looking statements. Actual results may differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot